LORDS MARK INDUSTRIES PUTS INDIA ON GLOBAL MEDTECH MAP

Lords Mark Industries is aligned with India's affordable, accessible healthcare mission

- 

In India's fast-evolving healthcare landscape, few companies have mirrored the country's transformation as compellingly as Lords Mark Industries Ltd. (LMIL). Over 27 years, LMIL has evolved from a promising venture into one of India's most future-ready business groups — one that stands at the intersection of healthcare innovation, technology, and sustainable growth.

At a time when global healthcare is being reshaped by the demand for affordability and accessibility, LMIL has aligned itself with India's national ambition — to emerge as a global MedTech and diagnostics powerhouse.

With a growing presence across biotechnology, medical diagnostics, and advanced medical devices, the company has built an integrated ecosystem that brings together research, manufacturing, and digital health intelligence.

Aligning Vision with National Priorities

The company's trajectory reflects a rare clarity of purpose: to use technology to democratise healthcare. Over the last decade, LMIL has directed nearly all of its innovation and investment into healthcare, building a model that combines India's strengths in R&D, engineering, and cost efficiency with global standards of precision and compliance.

Its growth aligns closely with the country's Make in India and Atmanirbhar Bharat (self-reliant India) missions. LMIL's facilities comply with US FDA, ISO 13485:2016, WHO-GMP, and CDSCO standards — placing it among the select few Indian MedTech manufacturers trusted globally for quality, reliability, and scalability.

By securing US FDA registration in 2025 for its surgical consumables, orthopedic supports, and hygiene products, the company joined the elite club of Indian manufacturers catering to regulated markets such as the United States, Europe, and the Middle East. This milestone not only validates its technological depth but also reinforces India's growing influence in the global healthcare supply chain.